SCHEMBL25017481

SCHEMBL25017481

CN1CC[C@@H](C(=O)C(C)(C)C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.40
ALDH1A1 P00352 1/20 0.36
RIPK1 Q13546 1/20 0.35
LMNA P02545 1/20 0.34
CNR2 P34972 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SSTR1 P30872 1/20 0.32
SSTR4 P31391 1/20 0.32
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
HTT P42858 1/20 0.32
NAMPT P43490 1/20 0.32
ITGB3 P05106 1/20 0.31
ITGA2B P08514 1/20 0.31
F2R P25116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015425 1.00 PKM (0.40) PKMALDH1A1RIPK1LMNACNR2
SCHEMBL16886297 1.00 PKM (0.40) PKMALDH1A1RIPK1LMNACNR2
SCHEMBL22570079 0.88 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2HTTITGB3
SCHEMBL20812606 0.88 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2HTTITGB3
SCHEMBL22570073 0.88 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2HTTITGB3
SCHEMBL8906192 0.87 RIPK1 (0.40) ALDH1A1RIPK1LMNASMN1; SMN2GNAI3
SCHEMBL18199643 0.82 POLB (0.31)
SCHEMBL20467891 0.79 LMNA (0.34) LMNASMN1; SMN2
SCHEMBL27889752 0.78 PKM (0.44) PKMALDH1A1RIPK1LMNACNR2
SCHEMBL28024236 0.78 PKM (0.44) PKMALDH1A1RIPK1LMNACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023559-A1 ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC (US) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023559-A1 ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNJ2, KCNA3, KCNH3 PKM 340/4885ALDH1A1 1871/4885RIPK1 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.